These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17508001)

  • 1. HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells.
    Muzio M; Scielzo C; Frenquelli M; Bachi A; De Palma M; Alessio M; Ghia P; Caligaris-Cappio F
    Leukemia; 2007 Sep; 21(9):2067-70. PubMed ID: 17508001
    [No Abstract]   [Full Text] [Related]  

  • 2. HS1 has a central role in the trafficking and homing of leukemic B cells.
    Scielzo C; Bertilaccio MT; Simonetti G; Dagklis A; ten Hacken E; Fazi C; Muzio M; Caiolfa V; Kitamura D; Restuccia U; Bachi A; Rocchi M; Ponzoni M; Ghia P; Caligaris-Cappio F
    Blood; 2010 Nov; 116(18):3537-46. PubMed ID: 20530793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection.
    Scielzo C; Ten Hacken E; Bertilaccio MT; Muzio M; Calissano C; Ghia P; Caligaris-Cappio F
    Leuk Lymphoma; 2010 Aug; 51(8):1371-4. PubMed ID: 20687794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From a 2DE-gel spot to protein function: lesson learned from HS1 in chronic lymphocytic leukemia.
    Apollonio B; Bertilaccio MT; Restuccia U; Ranghetti P; Barbaglio F; Ghia P; Caligaris-Cappio F; Scielzo C
    J Vis Exp; 2014 Oct; (92):e51942. PubMed ID: 25350848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
    Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
    J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
    ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
    Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
    Hasan MK; Yu J; Chen L; Cui B; Widhopf Ii GF; Rassenti L; Shen Z; Briggs SP; Kipps TJ
    Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The APRIL paradox in normal versus malignant B cell biology.
    van Attekum MH; Kater AP; Eldering E
    Cell Death Dis; 2016 Jun; 7(6):e2276. PubMed ID: 27336720
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction.
    Borge M; Delpino MV; Podaza E; Stanganelli C; Palau-Nagore V; Roisman A; Slavutsky I; Palacios MF; Ledesma I; Arra A; Díaz A; Giordano M; Gamberale R; Bezares RF
    Leuk Lymphoma; 2016 Oct; 57(10):2468-71. PubMed ID: 26911473
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells.
    Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
    Leukemia; 2004 Jan; 18(1):41-7. PubMed ID: 14574334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.
    Boissard F; Laurent C; Ramsay AG; Quillet-Mary A; Fournié JJ; Poupot M; Ysebaert L
    Blood Cancer J; 2016 Jan; 6(1):e381. PubMed ID: 26771807
    [No Abstract]   [Full Text] [Related]  

  • 13. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
    Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
    J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the CLL B-lymphocyte?
    Dighiero G; Kipps T; Schroeder HW; Chiorazzi N; Stevenson F; Silberstein LE; Caligaris-Cappio F; Ferrarini M
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():13-39. PubMed ID: 9021706
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
    Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
    Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the B-cell receptor in chronic lymphocytic leukemia: where do we stand?
    Fais F; Bruno S; Ghiotto F
    Ital J Anat Embryol; 2010; 115(1-2):79-84. PubMed ID: 21072994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
    Gattazzo C; Martini V; Frezzato F; Trimarco V; Tibaldi E; Castelli M; Facco M; Zonta F; Brunati AM; Zambello R; Semenzato G; Trentin L
    Haematologica; 2014 Jun; 99(6):1069-77. PubMed ID: 24532043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.
    Barbier S; Chatre L; Bras M; Sancho P; Roué G; Virely C; Yuste VJ; Baudet S; Rubio M; Esquerda JE; Sarfati M; Merle-Béral H; Susin SA
    Haematologica; 2009 Apr; 94(4):507-17. PubMed ID: 19278964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
    Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
    Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.